PMC:7534795 / 43254-43365 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T324","span":{"begin":76,"end":85},"obj":"Disease"}],"attributes":[{"id":"A324","pred":"mondo_id","subj":"T324","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"\u003e upper limit normal\n• Phase 3 Cohort 1: Sarilumab in hospitalized critical infection receiving mechanical vent"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T336","span":{"begin":31,"end":37},"obj":"Chemical"}],"attributes":[{"id":"A336","pred":"chebi_id","subj":"T336","obj":"http://purl.obolibrary.org/obo/CHEBI_34935"}],"text":"\u003e upper limit normal\n• Phase 3 Cohort 1: Sarilumab in hospitalized critical infection receiving mechanical vent"}

{"project":"LitCovid-sentences","denotations":[{"id":"T346","span":{"begin":21,"end":40},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"\u003e upper limit normal\n• Phase 3 Cohort 1: Sarilumab in hospitalized critical infection receiving mechanical vent"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1345","span":{"begin":76,"end":85},"obj":"Disease"}],"attributes":[{"id":"A1345","pred":"tao:has_database_id","subj":"1345","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"\u003e upper limit normal\n• Phase 3 Cohort 1: Sarilumab in hospitalized critical infection receiving mechanical vent"}